Evidence· June 13, 2026 · 11 min read
EULAR 2026 readouts: CD40L lupus win, IL-17 beats IL-23, off-the-shelf cell therapy
By Ran Chen#Immunology#Clinical Evidence#Pivotal Trials
Topic
CAR-T
CAR-T approvals, site readiness, inpatient/outpatient economics, outcomes evidence, and payer access.
Pricing & Access· June 10, 2026 · 10 min read
Bispecific antibody access landscape for myeloma and lymphoma
Pricing & Access· June 10, 2026 · 9 min read
CAR-T cell therapy access landscape: seven products in 2026
By Ran Chen#CAR-T#Oncology#Prior Authorization
Manufacturing· June 9, 2026 · 6 min read
The commercial ecosystem behind cell & gene therapy: ASGCT 2026 exhibitors mapped
Pricing & Access· May 27, 2026 · 12 min read
Yescarta vs Tecartus CAR-T access guide
By Ran Chen#Oncology#CAR-T#Prior Authorization